Form 4: AngioDynamics EVP and CFO Stephen Trowbridge Reports Share Transactions
SEC Form 4 Filing
Stephen Trowbridge, EVP and CFO of AngioDynamics, reports the acquisition and disposition of company shares related to vesting of performance share units and restricted stock units.
Summary
- On July 17, 2024, Stephen Trowbridge, EVP and CFO of AngioDynamics, acquired 11,142 shares of common stock due to the vesting and settlement of performance share units granted on July 21, 2021.
- Trowbridge also disposed of 4,016 shares on July 17, 2024, and 2,585 shares on July 19, 2024, to satisfy tax withholding obligations related to the vesting of performance share units and restricted stock units, respectively.
- Following these transactions, Trowbridge beneficially owns 171,011 shares of AngioDynamics common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing insider transactions, which carries a neutral sentiment. The transactions are related to compensation and tax obligations, not necessarily indicative of a strong positive or negative outlook.
Industry Context
Form 4 filings are a routine part of compliance for corporate insiders and provide transparency into their transactions in company stock. These filings are closely watched by investors seeking insights into management's perspective on the company's prospects.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in beneficial ownership by a company executive.
- Employees who hold similar performance share units or restricted stock units may be interested in the details of the vesting and tax implications.
Key Dates
| Date | Description |
|---|---|
| July 21, 2021 | Date of grant of performance share units to the reporting person. |
| July 19, 2023 | Date of grant of restricted stock units to the reporting person. |
| July 17, 2024 | Acquisition of 11,142 shares and disposition of 4,016 shares to cover tax obligations. |
| July 19, 2024 | Disposition of 2,585 shares to cover tax obligations. |
| August 02, 2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.